[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4110/in.2013.13.5.177

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy

Park, Yeong-Min (Department of Immunology, School of Medicine, Konkuk University)
Lee, Seung Jun (Department of Immunology, School of Medicine, Konkuk University)
Kim, Young Seob (Department of Immunology, School of Medicine, Konkuk University)
Lee, Moon Hee (Department of Immunology, School of Medicine, Konkuk University)
Cha, Gil Sun (Department of Immunology, School of Medicine, Konkuk University)
Jung, In Duk (Department of Immunology, School of Medicine, Konkuk University)
Kang, Tae Heung (Department of Immunology, School of Medicine, Konkuk University)
Han, Hee Dong (Department of Immunology, School of Medicine, Konkuk University)

Publication Information

IMMUNE NETWORK / v.13, no.5, 2013 , pp. 177-183 More about this Journal

Abstract

Development of nano-sized carriers including nanoparticles, nanoemulsions or liposomes holds great potential for advanced delivery systems for cancer immunotherapy, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to specific target sites. Successful development of nanotechnology based platform in the field of immunotherapy will allow the application of vaccines, adjuvants and immunomodulatory drugs that improve clinical outcomes for immunological diseases. Here, we review current nanoparticle-based platforms in the efficacious delivery of vaccines in cancer immunotherapy.

Keywords

Nanoparticle; Cancer; Vaccine; Immunotherapy;

Citations & Related Records

Times Cited By KSCI : 2 (Citation Analysis)

Reference
Cited By KSCI

1	Yan, W., W. Chen, and L. Huang. 2008. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine. J. Control. Release 130: 22-28. DOI
2	Venkataraman, S., J. L. Hedrick, Z. Y. Ong, C. Yang, P. L. Ee, P. T. Hammond, and Y. Y. Yang. 2011. The effects of polymeric nanostructure shape on drug delivery. Adv. Drug Deliv. Rev. 63: 1228-1246. DOI
3	Florez, L., C. Herrmann, J. M. Cramer, C. P. Hauser, K. Koynov, K. Landfester, D. Crespy, and V. Mailander. 2012. How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells. Small 8: 2222-2230. DOI
4	Alexis, F., E. Pridgen, L. K. Molnar, and O. C. Farokhzad. 2008. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5: 505-515. DOI
5	Kelly, C., C. Jefferies, and S. A. Cryan. 2011. Targeted liposomal drug delivery to monocytes and macrophages. J. Drug Deliv. 2011: 727241.
6	Nguyen, D. N., K. P. Mahon, G. Chikh, P. Kim, H. Chung, A. P. Vicari, K. T. Love, M. Goldberg, S. Chen, A. M. Krieg, J. Chen, R. Langer, and D. G. Anderson. 2012. Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery. Proc. Natl. Acad. Sci. USA 109: E797-803. DOI
7	Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82. DOI
8	Lee, I. H., H. K. Kwon, S. An, D. Kim, S. Kim, M. K. Yu, J. H. Lee, T. S. Lee, S. H. Im, and S. Jon. 2012. Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. Angew. Chem. Int. Ed. Engl. 51: 8800-8805. DOI
9	Craparo, E. F. and M. L. Bondi. 2012. Application of polymeric nanoparticles in immunotherapy. Curr. Opin. Allergy Clin. Immunol. 12: 658-664. DOI
10	Smith, D. M., J. K. Simon, and J. R. Baker, Jr. 2013. Applications of nanotechnology for immunology. Nat. Rev. Immunol. 13: 592-605. DOI
11	Serda, R. E. 2013. Particle platforms for cancer immunotherapy. Int. J. Nanomedicine 8: 1683-1696.
12	Rodriguez-Limas, W. A., K. Sekar, and K. E. Tyo. 2013. Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development. Curr. Opin. Biotechnol. In press: http://dx.doi.org/10.1016/j.copbio. 2013.02.008.
13	Yuba, E., A. Harada, Y. Sakanishi, S. Watarai, and K. Kono. 2013. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. Biomaterials 34: 3042-3052. DOI
14	Syed, S., A. Zubair, and M. Frieri. 2013. Immune response to nanomaterials: implications for medicine and literature review. Curr. Allergy. Asthma Rep. 13: 50-57. DOI
15	Ditto, A. J., P. N. Shah, and Y. H. Yun. 2009. Non-viral gene delivery using nanoparticles. Expert. Opin. Drug Deliv. 6: 1149-1160. DOI
16	Hua, S. and P. J. Cabot. 2013. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition. Pain Physician 16: E199-216.
17	Gregory, A. E., R. Titball, and D. Williamson. 2013. Vaccine delivery using nanoparticles. Front Cell Infect. Microbiol. 3:1-13. doi: 10.3389/fcimb.2013.00013
18	DeMuth, P. C., J. J. Moon, H. Suh, P. T. Hammond, and D. J. Irvine. 2012. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. ACS Nano 6: 8041-8051. DOI
19	Hadinoto, K., A. Sundaresan, and W. S. Cheow. 2013. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur. J. Pharm. Biopharm. In press : http://dx.doi.org/10.1016/j.ejpb.2013.07.
20	Pawar, D., S. Mangal, R. Goswami, and K. S. Jaganathan. 2013. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur. J. Pharm. Biopharm. In press : http://dx.doi. org/10.1016/j.ejpb.2013.06.017
21	Lee, J. S., D. H. Kim, C. M. Lee, T. K. Ha, K. T. Noh, J. W. Park, D. R. Heo, K. H. Son, I. D. Jung, E. K. Lee, Y. K. Shin, S. C. Ahn, and Y. M. Park. 2011. Deoxypodophyllotoxin induces a Th1 response and enhances the antitumor efficacy of a dendritic cell-based vaccine. Immune Netw. 11: 79-94. DOI
22	Noh, K. T., S. J. Shin, K. H. Son, I. D. Jung, H. K. Kang, S. J. Lee, E. K. Lee, Y. K. Shin, J. C. You, and Y. M. Park. 2012. The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency. Exp. Mol. Med. 44: 340-349. DOI
23	Cho, N. H., T. C. Cheong, J. H. Min, J. H. Wu, S. J. Lee, D. Kim, J. S. Yang, S. Kim, Y. K. Kim, and S. Y. Seong. 2011. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6: 675-682. DOI
24	Xiang, S. D., K. Wilson, S. Day, M. Fuchsberger, and M. Plebanski. 2013. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. Methods 60: 232-241. DOI
25	Noh, Y. W., J. H. Hong, S. M. Shim, H. S. Park, H. H. Bae, E. K. Ryu, J. H. Hwang, C. H. Lee, S. H. Cho, M. H. Sung, H. Poo, and Y. T. Lim. 2013. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity. Angew. Chem. Int. Ed. Engl. 52: 7684-7689. DOI
26	Prasad, S., V. Cody, J. K. Saucier-Sawyer, W. M. Saltzman, C. T. Sasaki, R. L. Edelson, M. A. Birchall, and D. J. Hanlon. 2011. Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Nanomedicine 7: 1-10. DOI
27	Silva, J. M., M. Videira, R. Gaspar, V. Preat, and H. F. Florindo. 2013. Immune system targeting by biodegradable nanoparticles for cancer vaccines. J. Control. Release 168: 179-199. DOI
28	Nembrini, C., A. Stano, K. Y. Dane, M. Ballester, A. J. van der Vlies, B. J. Marsland, M. A. Swartz, and J. A. Hubbell. 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc. Natl. Acad. Sci. USA 108: E989-997. DOI
29	Andrade, F., D. Rafael, M. Videira, D. Ferreira, A. Sosnik, and B. Sarmento. 2013. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv. Drug Deliv. Rev. In press : http://dx.doi.org/10.1016/j.addr. 2013.07.020
30	Suh, W. H., K. S. Suslick, G. D. Stucky, and Y. H. Suh. 2009. Nanotechnology, nanotoxicology, and neuroscience. Prog. Neurobiol. 87: 133-170. DOI
31	Zhang, L., F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, and O. C. Farokhzad. 2008. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83: 761-769. DOI
32	Kim, J. H., Y. W. Noh, M. B. Heo, M. Y. Cho, and Y. T. Lim. 2012. Multifunctional hybrid nanoconjugates for efficient in vivo delivery of immunomodulating oligonucleotides and enhanced antitumor immunity. Angew. Chem. Int. Ed. Engl. 51: 9670-9673. DOI
33	Kotagiri, N., J. S. Lee, and J. W. Kim. 2013. Selective pathogen targeting and macrophage evading carbon nanotubes through dextran sulfate coating and PEGylation for photothermal theranostics. J. Biomed. Nanotechnol. 9: 1008-1016. DOI
34	Kanekiyo, M., C. J. Wei, H. M. Yassine, P. M. McTamney, J. C. Boyington, J. R. Whittle, S. S. Rao, W. P. Kong, L. Wang, and G. J. Nabel. 2013. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499: 102-106. DOI
35	Perry, J. L., K. G. Reuter, M. P. Kai, K. P. Herlihy, S. W. Jones, J. C. Luft, M. Napier, J. E. Bear, and J. M. DeSimone. 2012. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 12: 5304-5310. DOI
36	Demento, S. L., S. C. Eisenbarth, H. G. Foellmer, C. Platt, M. J. Caplan, W. Mark Saltzman, I. Mellman, M. Ledizet, E. Fikrig, R. A. Flavell, and T. M. Fahmy. 2009. Inflammasomeactivating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27: 3013-3021. DOI
37	Diwan, M., M. Tafaghodi, and J. Samuel. 2002. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J. Control. Release 85: 247-262. DOI
38	Clawson, C., C. T. Huang, D. Futalan, D. M. Seible, R. Saenz, M. Larsson, W. Ma, B. Minev, F. Zhang, M. Ozkan, C. Ozkan, S. Esener, and D. Messmer. 2010. Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. Nanomedicine 6: 651-661. DOI
39	Liu, S. Y., W. Wei, H. Yue, D. Z. Ni, Z. G. Yue, S. Wang, Q. Fu, Y. Q. Wang, G. H. Ma, and Z. G. Su. 2013. Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy. Biomaterials 34: 8291-8300. DOI
40	Shen, H., A. L. Ackerman, V. Cody, A. Giodini, E. R. Hinson, P. Cresswell, R. L. Edelson, W. M. Saltzman, and D. J. Hanlon. 2006. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsu lated in biodegradable nanoparticles. Immunology 117: 78-88. DOI
41	Shima, F., T. Akagi, T. Uto, and M. Akashi, 2013. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(gamma-glutamic acid) nanoparticles. Biomaterials 34: 9709-9716. DOI
42	Reddy, S. T., A. J. van der Vlies, E. Simeoni, V. Angeli, G. J. Randolph, C. P. O'Neil, L. K. Lee, M. A. Swartz, and J. A. Hubbell. 2007. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25: 1159-1164. DOI
43	Bachmann, M. F. and G. T. Jennings. 2010. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10: 787-796. DOI
44	Foged, C., B. Brodin, S. Frokjaer, and A. Sundblad. 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm. 298: 315-322. DOI
45	Mottram, P. L., D. Leong, B. Crimeen-Irwin, S. Gloster, S. D. Xiang, J. Meanger, R. Ghildyal, N. Vardaxis, and M. Plebanski. 2007. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol. Pharm. 4: 73-84. DOI
46	Thurn, K. T., E. Brown, A. Wu, S. Vogt, B. Lai, J. Maser, T. Paunesku, and G. E. Woloschak. 2007. Nanoparticles for applications in cellular imaging. Nanoscale Res. Lett. 2: 430-441. DOI

None	(2013) Procedia in vaccinology Development of a Novel Nanoparticle-based Therapeutic Vaccine for Breast Cancer Immunotherapy / 8 (None) , 62
2	(2013) New horizons in translational medicine : official publication of the European Society for Translational Medicine Revolutionary impact of nanovaccines on immunotherapy / 2 (2) , 44
6	(2013) Biomedical research and therapy Stem cell technology and engineering for cancer treatment / 2 (6) , 13
7	Marina A Dobrovolskaia. (2015) Expert opinion on drug delivery Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics / 12 (7) , 1163
9	(2013) Expert review of vaccines Gold nanoparticles and vaccine development / 14 (9) , 1197
11	Alka Yadav. (2013) Biotechnology letters. : a monthly journal for the rapid communication of results and developments in all aspects of biotechnology Fungi as an efficient mycosystem for the synthesis of metal nanoparticles: progress and key aspects of research / 37 (11) , 2099
5	(2016) Critical reviews in biotechnology The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases / 36 (5) , 777
6	(2016) Nanomedicine The effect of nanoparticle size on <I>in vivo</I> pharmacokinetics and cellular interaction / 11 (6) , 673
18	(2013) Nanomedicine Current <I>in vitro</I> approaches to assess nanoparticle interactions with lung cells / 11 (18) , 2457
3	(2013) Chemical science Immunological properties of gold nanoparticles / 8 (3) , 1719
None	(2017) Frontiers in immunology Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy / 8 (None) , 774
None	(2013) Frontiers in immunology Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy / 8 (None) , 879
1	Nahideh Asadi. (2013) Artificial cells, nanomedicine, and biotechnology Application of nanostructured drug delivery systems in immunotherapy of cancer: a review / 45 (1) , 18
None	(2013) Frontiers in molecular biosciences The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies / 4 (None) , 52
1	(2013) Studies in agricultural economics Triple helix networks matching knowledge demand and supply in seven Dutch horticulture Greenport regions / 119 (1) , 34
1	(2017) Cancer nanotechnology Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles / 8 (1) , 7
9	(2013) Dalton transactions : an international journal of inorganic chemistry High adjuvant activity of layered double hydroxide nanoparticles and nanosheets in anti-tumour vaccine formulations / 47 (9) , 2956
37	(2013) Chemical science pH/hypoxia programmable triggered cancer photo-chemotherapy based on a semiconducting polymer dot hybridized mesoporous silica framework / 9 (37) , 7390
42	(2013) ACS applied materials & interfaces A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses / 10 (42) , 35745
4	(2013) Vaccines Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells / 6 (4) , 75
3	(2019) Advanced functional materials Functional Nanomaterials Optimized to Circumvent Tumor Immunological Tolerance / 29 (3) , 1806087
3	(2013) Journal of pharmaceutical investigation Physicochemical properties of particulate vaccine adjuvants: their pivotal role in modulating immune responses / 49 (3) , 279
17	(2013) Current pharmaceutical design Nanoparticles: Properties and Applications in Cancer Immunotherapy / 25 (17) , 1962
7	(2013) Drug development and industrial pharmacy Mannose functionalized plain and endosomolytic nanocomposite(s)-based approach for the induction of effective antitumor immune response in C57BL/6 mice melanoma model / 45 (7) , 1089
7	(2013) Biomedical optics express Gold nanoparticles in chemo-, immuno-, and combined therapy: review [Invited] / 10 (7) , 3152
11	(2013) Pharmaceutics Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles / 11 (11) , 590
11	(2013) Molecular pharmaceutics Modulation of Nanostructure-Based Lipopolysaccharide Active Immunotherapy in Cancer: Size and Composition Determine Short- and Long-Term Tolerability / 16 (11) , 4507
18	(2013) Journal of materials chemistry. B, Materials for biology and medicine A nano-based thermotherapy for cancer stem cell-targeted therapy / 8 (18) , 3985
7	(2013) ACS nano Nanotechnology for COVID-19: Therapeutics and Vaccine Research / 14 (7) , 7760
8	(2013) ACS biomaterials science & engineering Silk Fibroin Nanoadjuvant as a Promising Vaccine Carrier to Deliver the FimH-IutA Antigen for Urinary Tract Infection / 6 (8) , 4573
None	(2013) International journal of pharmaceutics Nanotechnological strategies for systemic microbial infections treatment: A review / 589 (None) , 119780
11	(2013) Expert review of vaccines Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges / 19 (11) , 1053
12	(2020) Advanced therapeutics An Antigen‐Delivery Protein Nanoparticle Combined with Anti‐PD‐1 Checkpoint Inhibitor Has Curative Efficacy in an Aggressive Melanoma Model / 3 (12) , 2000122
12	(2013) Pharmaceutics Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death / 12 (12) , 1165
None	(2021) International journal of nanomedicine Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System / 16 (None) , 2389
2	(2021) Vaccines The Use of Nanobiotechnology in Immunology and Vaccination / 9 (2) , 74
None	(2013) Frontiers in Materials The Potential of Calcium Phosphate Nanoparticles as Adjuvants and Vaccine Delivery Vehicles / 8 (None) , 788373
2	(2013) Biotechnology progress Nanoparticles in cancer immunotherapies: An innovative strategy / 37 (2) , None
4	(2013) Infekciâ i immunitet Enhancing the specific T cell immune response against micro- and nanoparticle immobilized antigen / 11 (4) , 777
10	(2013) Molecular pharmaceutics Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes / 18 (10) , 3832
11	(2013) Pharmaceuticals Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines / 14 (11) , 1173